SCHEMBL4513136

SCHEMBL4513136

CC(c1ccc(F)cc1)N1CCN(C(=O)c2cc3cc[nH]c3cc2Cl)[C@H](C)C1

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 14/20 0.49
MAPK14 Q16539 4/20 0.43
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4513134 1.00 GHSR (0.49) GHSRMAPK14POLBHPGD
SCHEMBL13936147 1.00 GHSR (0.49) GHSRMAPK14POLBHPGD
SCHEMBL4495539 0.82 MAPK14 (0.49) GHSRMAPK14
SCHEMBL4495543 0.82 MAPK14 (0.49) GHSRMAPK14
SCHEMBL4500424 0.81 CCR1 (0.51) GHSRMAPK14
SCHEMBL4500428 0.81 CCR1 (0.51) GHSRMAPK14
SCHEMBL4791284 0.80 MAPK14 (0.45) GHSRMAPK14
SCHEMBL14109775 0.80 MAPK14 (0.45) GHSRMAPK14
SCHEMBL4506730 0.79 MAPK14 (0.45) GHSRMAPK14POLBHPGD
SCHEMBL13936148 0.79 MAPK14 (0.45) GHSRMAPK14POLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7488744-B2 Indole-type derivatives as inhibitors of p38 kinase SCIOS, INC. (US) 2009-02-10 US disclosed
US-20070232617-A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF P38 KINASE SCIOS, INC. (US) 2007-10-04 US disclosed
US-7220763-B2 Indole-type derivatives as inhibitors of p38 kinase SCIOS, INC. (US) 2007-05-22 US disclosed
EP-1545528-A4 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF P38 KINASE SCIOS INC (US) 2006-07-26 EP disclosed
EP-1545528-A2 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF P38 KINASE SCIOS INC. (US) 2005-06-29 EP disclosed
US-20040142940-A1 Indole-type derivatives as inhibitors of p38 kinase SCIOS, INC. 2004-07-22 US disclosed
WO-2004022712-A2 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE SCIOS INC. (US) 2004-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142940-A1 Indole-type derivatives as inhibitors of p38 kinase MAPK1, MAPKAPK2, MAPK4 GHSR 3785/4885MAPK14 28/4885POLB 3632/4885
US-20070232617-A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF P38 KINASE MAPK1, MAPKAPK2, MAPKAPK5 GHSR 3604/4885MAPK14 38/4885POLB 3314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.